Esther Chun-Pin Chang

Esther Chun-Pin Chang, PhD, MPH

Languages spoken: English

Academic Information

Departments Adjunct - Family & Preventive Medicine

Divisions: Public Health

Esther Chun-Pin Chang is an Adjunct Assistant Professor in the Division of Public Health, Department of Family and Preventive Medicine, at the University of Utah. Dr. Chang completed her MPH and PhD in epidemiology at UCLA. Her research expertise encompasses cancer epidemiology, cancer survivorship, health disparities, and reproductive health. Her current work focuses on investigating long-term health outcomes among cancer survivors, using novel data linkage to identify cancer recurrence, and addressing health disparities among rural cancer survivors as well as Asian, Hawaiian, and Pacific Islander cancer survivors. In addition to her academic endeavors, Dr. Change is an enthusiast of skiing, stand-up paddleboarding, and indoor climbing.

Education History

Graduate Training UCLA Fielding School of Public Health
 PhD
UCLA Fielding School of Public Health
 MPH

Selected Publications

Journal Article

  1. Koric A, Chang CE, Lee YA, Wei M, Lee CJ, Tao R, Wang J, Tay D, Hashibe M (2024). Incident diabetes among older Asian, Native Hawaiian, and Pacific Islander women with breast cancer. JNCI Cancer Spectr, 8(4). (Read full article)
  2. Hu S, Chang CP, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Haaland B, Porucznik CA, Gren LH, Sanchez A, Lloyd S, ONeil B, Hashibe M (2023). Mental health outcomes in a population-based cohort of patients with prostate cancer. J Natl Cancer Inst, 116(3), 445-454. (Read full article)
  3. Hashibe M, Wei M, Lee CJ, Tao R, Koric A, Wang J, Daud A, Tay D, Shen J, Lee YA, Chang CE (2023). Incident Cardiovascular Disease Risk among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors. Cancer Epidemiol Biomarkers Prev, 33(1), 126-135. (Read full article)
  4. Koric A, Mark B, Chang CP, Lloyd S, Dodson M, Deshmukh VG, Newman M, Date A, Gren LH, Porucznik CA, Haaland B, Henry NL, Hashibe M (2023). Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study. Cancer Epidemiol Biomarkers Prev, 32(10), 1302-1311. (Read full article)
  5. Nielsen S, ONeil B, Chang CP, Mark B, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Henry NL, Lloyd S, Hashibe M (2023). Determining the association of rurality and cardiovascular disease among prostate cancer survivors. Urol Oncol, 41(10), 429.e15-429.e23. (Read full article)
  6. Huang D, Chang CE, Newman M, Deshmukh V, Snyder J, Date A, Galvao C, Lloyd S, Henry NL, ONeil B, Hashibe M (2023). Adverse health outcomes among rural prostate cancer survivors: A population-based study. Cancer Epidemiol, 86, 102430. (Read full article)
  7. Hu S, Chang CP, Snyder J, Deshmukh V, Newman M, Date A, Galvao C, Porucznik CA, Gren LH, Sanchez A, Lloyd S, Haaland B, ONeil B, Hashibe M (2023). Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer. JCO Clin Cancer Inform, 7, e2300083. (Read full article)
  8. Chang CP, Ho TF, Snyder J, Dodson M, Deshmukh V, Newman M, Date A, Henry NL, Hashibe M (2023). Breast cancer survivorship and sexual dysfunction: a population-based cohort study. Breast Cancer Res Treat, 200(1), 103-113. (Read full article)
  9. Anzai Y, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Galvao C, Monroe M, Hashibe M (2023). Surveillance Imaging with PET/CT and CT and/or MRI for Head and Neck Cancer and Mortality: A Population-based Study. Radiology, 307(2), e212915. (Read full article)
  10. Shrestha G, Chang CP, Pun CB, Gautam DK, Siwakoti B, Sapkota A, Hashibe M (2022). Differences in risk factors for head and neck cancer among men and women in Nepal: A case-control study. Cancer Epidemiol, 82, 102319. (Read full article)
  11. Hu S, Baraghoshi D, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Peoples AR, Gaffney D, Hashibe M (2022). Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer Med, 12(2), 1801-1812. (Read full article)
  12. Chang CP, Wilson CM, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Stanford JB, Gaffney D, Mooney K, Hashibe M (2022). Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study. Support Care Cancer, 31(1), 51. (Read full article)
  13. Ayres S, Gee A, Kim S, Hashibe M, Praag A, Kaiser D, Chang CP, Brandt HM, Kepka D (2021). Human Papillomavirus Vaccination Knowledge, Barriers, and Recommendations Among Healthcare Provider Groups in the Western United States. J Cancer Educ, 37(6), 1816-1823. (Read full article)
  14. Mann S, Christini K, Chai Y, Chang CP, Hashibe M, Kepka D (2022). Vaccine hesitancy and COVID-19 immunization among rural young adults. Prev Med Rep, 28, 101845. (Read full article)
  15. Koric A, Chang CP, Mark B, Rowe K, Snyder J, Dodson M, Deshmukh VG, Newman MG, Fraser AM, Smith KR, Date AP, Gren LH, Porucznik CA, Haaland BA, Henry NL, Hashibe M (2022). Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort study. Cancer, 128(14), 2826-2835. (Read full article)
  16. Hu Q, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Gren LH, Porucznik C, Stanford JB, Gaffney D, Henry NL, Lopez I, Hashibe M (2021). Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort. JNCI Cancer Spectr, 5(2). (Read full article)
  17. Chang CP, Meyers TJ, Fu A, Zhang MY, Tashkin DP, Rao JY, Cozen W, Mack TM, Hashibe M, Morgenstern H, Zhang ZF (2020). Dietary glycemic index, glycemic load, and lung cancer risk: A case-control study in Los Angeles County. Cancer Epidemiol, 69, 101824. (Read full article)
  18. Chang CP, Siwakoti B, Sapkota A, Gautam DK, Lee YA, Monroe M, Hashibe M (2019). Tobacco smoking, chewing habits, alcohol drinking and the risk of head and neck cancer in Nepal. Int J Cancer, 147(3), 866-875. (Read full article)
  19. Chang CP, Chen Y, Blackburn B, Abdelaziz S, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Stanford JB, Porucznik CA, Ose J, Fraser A, Smith K, Doherty J, Gaffney D, Hashibe M (2020). Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study. Gynecol Oncol, 157(2), 529-535. (Read full article)
  20. Chang CP, La Vecchia C, Serraino D, Olshan AF, Zevallos JP, Morgenstern H, Levi F, Garavello W, Kelsey K, McClean M, Chen C, Schwartz SM, Schantz S, Yu GP, Boffetta P, Hashibe M, Lee YA, Parpinel M, Augustin LSA, Turati F, Zhang ZF, Edefonti V (2020). Dietary glycaemic index, glycaemic load and head and neck cancer risk: a pooled analysis in an international consortium. Br J Cancer, 122(6), 745-748. (Read full article)
  21. Stanford JB, Schliep KC, Chang CP, OSullivan JP, Porucznik CA (2019). Comparison of woman-picked, expert-picked, and computer-picked Peak Day of cervical mucus with blinded urine luteinising hormone surge for concurrent identification of ovulation. Paediatr Perinat Epidemiol, 34(2), 105-113. (Read full article)
  22. Chang CP, Chang SC, Chuang SC, Berthiller J, Ferro G, Matsuo K, Wnsch-Filho V, Toporcov TN, de Carvalho MB, La Vecchia C, Olshan AF, Zevallos JP, Serraino D, Muscat J, Sturgis EM, Li G, Morgenstern H, Levi F, Dal Maso L, Smith E, Kelsey K, McClean M, Vaughan TL, Lazarus P, Ramroth H, Chen C, Schwartz SM, Winn DM, Bosetti C, Edefonti V, Garavello W, Negri E, Hayes RB, Purdue MP, Boccia S, Cadoni G, Shangina O, Koifman R, Curado MP, Vilensky M, Swiatkowska B, Herrero R, Franceschi S, Benhamou S, Fernandez L, Menezes AMB, Daudt AW, Mates D, Schantz S, Yu GP, Lissowska J, Brenner H, Fabianova E, Rudnai P, Brennan P, Boffetta P, Zhang ZF, Hashibe M, Lee YA (2019). Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE). Cancer Epidemiol, 63, 101615. (Read full article)
  23. Chen CH, Chang CP, Wu FY, Liu CL, Peng CT, Lin CW (2011). Prevalence of human herpesvirus 8 DNA in peripheral blood mononuclear cells of acute and chronic leukemia patients in Taiwan. FEMS Immunol Med Microbiol, 61(3), 356-8. (Read full article)
  24. Yang TC, Chang CP, Lan YC, Liu CL, Shih MC, Wu FY, Lin CW (2009). Recombinant ORF66 and ORFK12 antigens for the detection of human herpesvirus 8 antibodies in HIV-positive and -negative patients. Biotechnol Lett, 31(5), 629-37. (Read full article)
  25. Lin CW, Chang CP, Wu FY, Liu CL (2008). Comparative prevalence of plasma human herpesvirus 8 DNA in sexual contact and intravenous injection routes of HIV transmission. FEMS Immunol Med Microbiol, 52(3), 428-30. (Read full article)